Department of Endocrinology, Osteoporosis and Bone Metabolism Unit, Singapore General Hospital, 20, College Road, Academia, Singapore, 169856, Singapore.
Synthesis Medical NZ Limited, Pukekohe, Auckland, New Zealand.
Osteoporos Int. 2021 Jul;32(7):1249-1275. doi: 10.1007/s00198-020-05742-0. Epub 2021 Jan 27.
Guidelines for doctors managing osteoporosis in the Asia-Pacific region vary widely. We compared 18 guidelines for similarities and differences in five key areas. We then used a structured consensus process to develop clinical standards of care for the diagnosis and management of osteoporosis and for improving the quality of care.
Minimum clinical standards for assessment and management of osteoporosis are needed in the Asia-Pacific (AP) region to inform clinical practice guidelines (CPGs) and to improve osteoporosis care. We present the framework of these clinical standards and describe its development.
We conducted a structured comparative analysis of existing CPGs in the AP region using a "5IQ" model (identification, investigation, information, intervention, integration, and quality). One-hundred data elements were extracted from each guideline. We then employed a four-round Delphi consensus process to structure the framework, identify key components of guidance, and develop clinical care standards.
Eighteen guidelines were included. The 5IQ analysis demonstrated marked heterogeneity, notably in guidance on risk factors, the use of biochemical markers, self-care information for patients, indications for osteoporosis treatment, use of fracture risk assessment tools, and protocols for monitoring treatment. There was minimal guidance on long-term management plans or on strategies and systems for clinical quality improvement. Twenty-nine APCO members participated in the Delphi process, resulting in consensus on 16 clinical standards, with levels of attainment defined for those on identification and investigation of fragility fractures, vertebral fracture assessment, and inclusion of quality metrics in guidelines.
The 5IQ analysis confirmed previous anecdotal observations of marked heterogeneity of osteoporosis clinical guidelines in the AP region. The Framework provides practical, clear, and feasible recommendations for osteoporosis care and can be adapted for use in other such vastly diverse regions. Implementation of the standards is expected to significantly lessen the global burden of osteoporosis.
亚太地区医生管理骨质疏松症的指南差异很大。我们比较了五个关键领域的 18 条指南,以了解其相似性和不同点。然后,我们使用结构化共识过程制定了骨质疏松症诊断和管理以及提高护理质量的临床护理标准。
亚太地区(AP)需要最低的骨质疏松症评估和管理临床标准,为临床实践指南(CPG)提供信息,并改善骨质疏松症护理。我们介绍了这些临床标准的框架,并描述了其制定过程。
我们使用“5IQ”模型(识别、调查、信息、干预、整合和质量)对亚太地区现有的 CPG 进行了结构化比较分析。从每个指南中提取了 100 个数据元素。然后,我们采用四轮 Delphi 共识过程来构建框架,确定指导的关键组成部分,并制定临床护理标准。
纳入了 18 条指南。5IQ 分析显示,指导意见在风险因素、生化标志物的使用、患者自我护理信息、骨质疏松症治疗指征、骨折风险评估工具的使用以及治疗监测方案等方面存在明显差异。在长期管理计划或临床质量改进策略和系统方面,指导意见很少。29 名亚太骨质疏松症委员会成员参加了 Delphi 过程,达成了 16 项临床标准的共识,对脆性骨折、椎体骨折评估以及将质量指标纳入指南的识别和调查、包括在内的标准的达成水平进行了定义。
5IQ 分析证实了之前关于亚太地区骨质疏松症临床指南明显异质性的轶事观察。该框架为骨质疏松症护理提供了实用、清晰和可行的建议,可适用于其他差异如此之大的地区。这些标准的实施预计将大大减轻全球骨质疏松症的负担。